2025-06-03-Jefferies-Chemring集团（CHG）_分析师会议回顾_8页_155kb

Chemring plc (CHG LN) Equity Research Summary

Key Financial Highlights

• Current Price: 486.50p
• Price Target: 530.00p ( +10%)
• 10W High-Low: 499p - 298p
• Market Cap: £1.4B / USD $1.9B

Analyst Conference Insights

1. Energetics Growth:

   • Norway-based Chemring Nobel (Energetics) serves non-integrated defense customers, avoiding vertical integration.
   • New blending facility in Germany (2026) supports sovereign capability in Europe.
   • Expansion costs (~60%) often funded via grants, enhancing project feasibility.

2. Geopolitical Tailwinds:

   • Strategic Defence Review aligns with Chemring’s offerings.
   • Concerns over spectrum dominance post-Ukraine fuel demand for Roke’s EW systems.
   • Deceive product (ground-based EW) sees interest in 15+ countries.

3. Substantial Projects & Capacity:

   • Norway greenfield plant feasibility: Targeting ~£105m revenue to bridge the £150m FY30 revenue gap.
   • JBTDS (US Sensors contract): Incremental £30m+ revenue between FY24-FY30, but historical delays remain a risk.

Business Segments

• Sensors & Information: Focus on hardware; potential for international EW sales.
• Countermeasures & Energetics: Chemring Nobel (HMX/RDX) serves ~50/50 European/US defense orders; avoids vertical integration.

Valuation & Ratings

• Rating: BUY
• Target Price: 530p
• Valuation Method: SOTP (EV/Sales + EV/EBITA) for CY26F forecasts.
• Analysts: David Farrell, Andy Douglas, Vanessa Jeffriess, Richard Hill.

Risks

• US/UK defense budgets; regulatory hurdles (e.g., Roke’s international sales).
• Energetics capacity overcapacity and M&A execution risks.
• Technical delays on key programs (e.g., JBTDS contract).

Next Steps

• Defence Industrial Strategy: Next month’s release outlines national capabilities.
• Defence Investment Plan: Autumn update details funding scenarios.
• Investor Focus: Shift toward UK-based defense stocks due to stronger financials.